Structural Neuroimaging Markers of Cognitive Decline in Parkinson’s Disease

Cognitive impairment in patients with Parkinson’s disease is a major challenge since it has been established that 25 to 40% of patients will develop cognitive impairment early in the disease. Furthermore, it has been reported that up to 80% of Parkinsonian patients will eventually develop dementia....

Full description

Bibliographic Details
Main Authors: Alexandru Hanganu, Oury Monchi
Format: Article
Language:English
Published: Hindawi Limited 2016-01-01
Series:Parkinson's Disease
Online Access:http://dx.doi.org/10.1155/2016/3217960
id doaj-6efd0db6f876440d81d18efb681fc4a4
record_format Article
spelling doaj-6efd0db6f876440d81d18efb681fc4a42020-11-25T00:29:50ZengHindawi LimitedParkinson's Disease2090-80832042-00802016-01-01201610.1155/2016/32179603217960Structural Neuroimaging Markers of Cognitive Decline in Parkinson’s DiseaseAlexandru Hanganu0Oury Monchi1Department of Clinical Neurosciences and Department of Radiology, University of Calgary, Calgary, AB, T2N 1N4, CanadaDepartment of Clinical Neurosciences and Department of Radiology, University of Calgary, Calgary, AB, T2N 1N4, CanadaCognitive impairment in patients with Parkinson’s disease is a major challenge since it has been established that 25 to 40% of patients will develop cognitive impairment early in the disease. Furthermore, it has been reported that up to 80% of Parkinsonian patients will eventually develop dementia. Thus, it is important to improve the diagnosing procedures in order to detect cognitive impairment at early stages of development and to delay as much as possible the developing of dementia. One major challenge is that patients with mild cognitive impairment exhibit measurable cognitive deficits according to recently established criteria, yet those deficits are not severe enough to interfere with daily living, hence being avoided by patients, and might be overseen by clinicians. Recent advances in neuroimaging brain analysis allowed the establishment of several anatomical markers that have the potential to be considered for early detection of cognitive impairment in Parkinsonian patients. This review aims to outline the neuroimaging possibilities in diagnosing cognitive impairment in patients with Parkinson’s disease and to take into consideration the near-future possibilities of their implementation into clinical practice.http://dx.doi.org/10.1155/2016/3217960
collection DOAJ
language English
format Article
sources DOAJ
author Alexandru Hanganu
Oury Monchi
spellingShingle Alexandru Hanganu
Oury Monchi
Structural Neuroimaging Markers of Cognitive Decline in Parkinson’s Disease
Parkinson's Disease
author_facet Alexandru Hanganu
Oury Monchi
author_sort Alexandru Hanganu
title Structural Neuroimaging Markers of Cognitive Decline in Parkinson’s Disease
title_short Structural Neuroimaging Markers of Cognitive Decline in Parkinson’s Disease
title_full Structural Neuroimaging Markers of Cognitive Decline in Parkinson’s Disease
title_fullStr Structural Neuroimaging Markers of Cognitive Decline in Parkinson’s Disease
title_full_unstemmed Structural Neuroimaging Markers of Cognitive Decline in Parkinson’s Disease
title_sort structural neuroimaging markers of cognitive decline in parkinson’s disease
publisher Hindawi Limited
series Parkinson's Disease
issn 2090-8083
2042-0080
publishDate 2016-01-01
description Cognitive impairment in patients with Parkinson’s disease is a major challenge since it has been established that 25 to 40% of patients will develop cognitive impairment early in the disease. Furthermore, it has been reported that up to 80% of Parkinsonian patients will eventually develop dementia. Thus, it is important to improve the diagnosing procedures in order to detect cognitive impairment at early stages of development and to delay as much as possible the developing of dementia. One major challenge is that patients with mild cognitive impairment exhibit measurable cognitive deficits according to recently established criteria, yet those deficits are not severe enough to interfere with daily living, hence being avoided by patients, and might be overseen by clinicians. Recent advances in neuroimaging brain analysis allowed the establishment of several anatomical markers that have the potential to be considered for early detection of cognitive impairment in Parkinsonian patients. This review aims to outline the neuroimaging possibilities in diagnosing cognitive impairment in patients with Parkinson’s disease and to take into consideration the near-future possibilities of their implementation into clinical practice.
url http://dx.doi.org/10.1155/2016/3217960
work_keys_str_mv AT alexandruhanganu structuralneuroimagingmarkersofcognitivedeclineinparkinsonsdisease
AT ourymonchi structuralneuroimagingmarkersofcognitivedeclineinparkinsonsdisease
_version_ 1725329567494701056